Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fate Therapeutics

Clinical trials sponsored by Fate Therapeutics, explained in plain language.

Fate Therapeutics FATE NASDAQ

A clinical-stage biopharmaceutical company developing cellular immunotherapies for cancer and immune disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Engineered stem cell therapy takes on Hard-to-Treat myeloma

Disease control Completed

This early-stage trial tested a new therapy called FT576, made from specially engineered stem cells that become cancer-fighting immune cells. It was given alone or with another drug, daratumumab, to 31 people with multiple myeloma that had returned or stopped responding to prior …

Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC